All participants from across the world are kindly invited by United Scientific Group (USG) to attend “Seventh International Conference on Drug Discovery and Lead Optimization" during November 1-3 at San Francisco, CA.
United Scientific Group (USG) successfully completed the First International Conference on Clinical Sciences and Drug Discovery in Baltimore, MD, USA during November 2-4, 2015 (CSDD-2015), Second Edition in Dundee, Scotland, UK during July 27-29, 2016 (CSDD-2016) and Third Edition in Reston, VA, USA during November 9-11, 2017 (CSDD-2017), The Fourth edition in San Francisco, CA during December 3-5, 2018 (Drug Discovery-2018), Fifth meeting in San Francisco, CA, USA during November 21-23, 2019 (Drug Discovery-2019) and Sixth edition as virtual during October 05-07, 2020 (Drug Discovery- 2020 Virtual). USG is now proudly announcing the Seventh international conference on Drug Discovery and Lead Optimization.
To produce drugs for new and difficult organic targets, drug development has extended to encompass a range of chemical entities that span a broad molecular weight spectrum, from typical small molecules to biologically based giant molecules and even cells. This variety has created new challenges for system scientists who are now required to plan and manufacture sturdy formulations for more than one modality.
Focusing from pre-clinical development to clinical development, this conference generates new ideas to spice up your pipeline by bringing together scientists, researchers, entrepreneurs, medical officers, CEO’s, CSO's, academicians and technologists from all over the world to debate the latest scientific advances in the field of drug discovery and development that help to shape current and future challenges in drug research. Now is the time to attend the seventh international conference on drug discovery and lead optimization. Be a part of this determined and dedicated community.
The theme of Drug Discovery-2023 is to facilitate the various viewpoints to deliver greater value to our target audience via various sessions.